|
|
||||||||
The Journal of Immunology, Vol 156, Issue 12 4707-4714, Copyright © 1996 by American Association of Immunologists
ARTICLES |
WE Fogler, K Volker, KL McCormick, M Watanabe, JR Ortaldo and RH Wiltrout
Laboratory of Experimental Immunology, Division of Basic Sciences, SAIC- Frederick, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702-1201, USA.
The mechanisms that regulate the adhesion and migration of NK cells to and across endothelium have been studied under nonflow conditions; however, the involvement of these processes in vivo is poorly understood. The present studies investigated the potential vascular adhesion ligand interactions that determine the in vivo recruitment of NK cells to pulmonary and hepatic parenchyma, and s.c. tumor after treatment of mice with biologic response modifiers. Seventy-two hours after a single injection of the cytokine-inducing agent poly-L-lysine stabilized in carboxylmethyl cellulose (poly-ICLC), pulmonary NK cell lytic activity and N-alpha-carbobenzoxy-L-lysine thiobenzyl ester (BLT)- esterase were augmented 29- and 14-fold, respectively, and the number of lung-associated NK cells was increased from 2.3 x 10(5) to 7.4 x 10(5). Similar fold increases in NK cell number and activity were observed in the liver and s.c. B16 melanoma after poly-ICLC injection or in the lungs and liver of mice treated with IL-2. Concomitant treatment of mice with alpha-VCAM-1 or alpha-VLA-4 mAb, but not alpha- ICAM-1 or alpha-LFA-1, abrogated the poly-ICLC and IL-2-induced increase in organ-associated NK activity and percentage of tumor- associated NK cells, resulted in a 61 to 76% decrease in pulmonary and hepatic NK cell number, and was independent of T and/or B cells. The decrease in NK cell number in organ parenchyma and tumor lesions was correlated to an increase in the number of NK cells in peripheral blood, but not bone marrow. These results demonstrate that VCAM-1/VLA-4 interaction is critically involved in the infiltration of newly recruited NK cells in to lung, liver, and progressively growing tumor after mobilization from the bone marrow.
This article has been cited by other articles:
![]() |
K.-Y. Lin, D. Lu, C.-F. Hung, S. Peng, L. Huang, C. Jie, F. Murillo, J. Rowley, Y.-C. Tsai, L. He, et al. Ectopic Expression of Vascular Cell Adhesion Molecule-1 as a New Mechanism for Tumor Immune Evasion Cancer Res., February 15, 2007; 67(4): 1832 - 1841. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-M. Lu, C. C. J. Zavitz, B. Chen, S. Kianpour, Y. Wan, and M. R. Stampfli Cigarette Smoke Impairs NK Cell-Dependent Tumor Immune Surveillance J. Immunol., January 15, 2007; 178(2): 936 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Subleski, V. L. Hall, T. C. Back, J. R. Ortaldo, and R. H. Wiltrout Enhanced Antitumor Response by Divergent Modulation of Natural Killer and Natural Killer T Cells in the Liver. Cancer Res., November 15, 2006; 66(22): 11005 - 11012. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chen, H. Kawashima, J. B. Lowe, L. L. Lanier, and M. Fukuda Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment J. Exp. Med., December 19, 2005; 202(12): 1679 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. R. Engwerda, M. Ato, S. Stager, C. E. Alexander, A. C. Stanley, and P. M. Kaye Distinct Roles for Lymphotoxin-{alpha} and Tumor Necrosis Factor in the Control of Leishmania donovani Infection Am. J. Pathol., December 1, 2004; 165(6): 2123 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ahmad and F. Alvarez Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis J. Leukoc. Biol., October 1, 2004; 76(4): 743 - 759. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Muhlen, J. Schumann, F. Wittke, S. Stenger, N. van Rooijen, L. van Kaer, and G. Tiegs NK Cells, but Not NKT Cells, Are Involved in Pseudomonas aeruginosa Exotoxin A-Induced Hepatotoxicity in Mice J. Immunol., March 1, 2004; 172(5): 3034 - 3041. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gastpar, C. Gross, L. Rossbacher, J. Ellwart, J. Riegger, and G. Multhoff The Cell Surface-Localized Heat Shock Protein 70 Epitope TKD Induces Migration and Cytolytic Activity Selectively in Human NK Cells J. Immunol., January 15, 2004; 172(2): 972 - 980. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ortaldo and H. A. Young Expression of IFN-{gamma} Upon Triggering of Activating Ly49D NK Receptors In Vitro and In Vivo: Costimulation with IL-12 or IL-18 Overrides Inhibitory Receptors J. Immunol., February 15, 2003; 170(4): 1763 - 1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okamoto, S. Kato, K. Oizumi, M. Kinoshita, Y. Inoue, K. Hoshino, S. Akira, A. N. J. Mckenzie, H. A. Young, and T. Hoshino Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia Blood, February 15, 2002; 99(4): 1289 - 1298. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Carlos Leukocyte recruitment at sites of tumor: dissonant orchestration J. Leukoc. Biol., August 1, 2001; 70(2): 171 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ortaldo, E. W. Bere, D. Hodge, and H. A. Young Activating Ly-49 NK Receptors: Central Role in Cytokine and Chemokine Production J. Immunol., April 15, 2001; 166(8): 4994 - 4999. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-W. Park, M. E. Gruys, K. McCormick, J.-K. Lee, J. Subleski, J. M. Wigginton, R. G. Fenton, J.-M. Wang, and R. H. Wiltrout Primary Hepatocytes from Mice Treated with IL-2/IL-12 Produce T Cell Chemoattractant Activity that Is Dependent on Monokine Induced by IFN-{{gamma}} (Mig) and Chemokine Responsive to {{gamma}}-2 (Crg-2) J. Immunol., March 15, 2001; 166(6): 3763 - 3770. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Prevost-Blondel, E. Roth, F. M. Rosenthal, and H. Pircher Crucial Role of TNF-{alpha} in CD8 T Cell-Mediated Elimination of 3LL-A9 Lewis Lung Carcinoma Cells In Vivo J. Immunol., April 1, 2000; 164(7): 3645 - 3651. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Glas, L. Franksson, C. Une, M.-L. Eloranta, C. Ohlen, A. Orn, and K. Karre Recruitment and Activation of Natural Killer (NK) Cells In Vivo Determined by the Target Cell Phenotype: An Adaptive Component of NK Cell-mediated Responses J. Exp. Med., January 3, 2000; 191(1): 129 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Ito, T. C. Back, A. N. Shakhov, R. H. Wiltrout, and S. A. Nedospasov Mice with a Targeted Mutation in Lymphotoxin-{alpha} Exhibit Enhanced Tumor Growth and Metastasis: Impaired NK Cell Development and Recruitment J. Immunol., September 1, 1999; 163(5): 2809 - 2815. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hoshino, R. H. Wiltrout, and H. A. Young IL-18 Is a Potent Coinducer of IL-13 in NK and T Cells: A New Potential Role for IL-18 in Modulating the Immune Response J. Immunol., May 1, 1999; 162(9): 5070 - 5077. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Fogler, K. Volker, M. Watanabe, J. M. Wigginton, P. Roessler, M. J. Brunda, J. R. Ortaldo, and R. H. Wiltrout Recruitment of Hepatic NK Cells by IL-12 Is Dependent on IFN-{gamma} and VCAM-1 and Is Rapidly Down-Regulated by a Mechanism Involving T Cells and Expression of Fas J. Immunol., December 1, 1998; 161(11): 6014 - 6021. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Smyth, J. M. Kelly, A. G. Baxter, H. Korner, and J. D. Sedgwick An Essential Role for Tumor Necrosis Factor in Natural Killer Cell-mediated Tumor Rejection in the Peritoneum J. Exp. Med., November 2, 1998; 188(9): 1611 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Mainiero, A. Gismondi, A. Soriani, M. Cippitelli, G. Palmieri, J. Jacobelli, M. Piccoli, L. Frati, and A. Santoni Integrin-mediated Ras-Extracellular Regulated Kinase (ERK) Signaling Regulates Interferon gamma Production in Human Natural Killer Cells J. Exp. Med., October 5, 1998; 188(7): 1267 - 1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Shaw, A. A. Maung, R. J. Steptoe, A. W. Thomson, and N. L. Vujanovic3 Expansion of Functional NK Cells in Multiple Tissue Compartments of Mice Treated with Flt3-Ligand: Implications for Anti-Cancer and Anti-Viral Therapy J. Immunol., September 15, 1998; 161(6): 2817 - 2824. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Kitson, P. M. Appasamy, U. Nannmark, P. Albertsson, M. K. Gabauer, and R. H. Goldfarb Matrix Metalloproteinases Produced by Rat IL-2-Activated NK Cells J. Immunol., May 1, 1998; 160(9): 4248 - 4253. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Ortaldo, R. Winkler-Pickett, A. T. Mason, and L. H. Mason The Ly-49 Family: Regulation of Cytotoxicity and Cytokine Production in Murine CD3+ Cells J. Immunol., February 1, 1998; 160(3): 1158 - 1165. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Andre, O. Spertini, S. Guia, P. Rihet, F. Dignat-George, H. Brailly, J. Sampol, P. J. Anderson, and E. Vivier Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin PNAS, March 28, 2000; 97(7): 3400 - 3405. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |